Atlas Trials

Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT01454349 · COMPLETED

Trial details

NCT number
NCT01454349
Sponsor
Sophiris Bio Corp
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Benign Prostatic Hyperplasia
Start date
2011-09-01
Primary completion
2013-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.